Lenmed Health Management Pty Ltd has acquired Daxina Medical Center (DMC)
Lenmed Health Pty Ltd, through its subsidiary Lenmed Health Management Pty Ltd. (Lenmed Health), has acquired the business assets of Daxina Medical Center (DMC), comprising the hospital land and buildings and all other assets and operations of the hospital, including the pharmacy assets and operations located on the land from which DMC conducts its hospital activities, for US$5.5 million.
Lenmed Health is an established hospital group in South Africa, operating multi-specialty hospital facilities in South Africa, Mozambique and Botswana, managing more than 1,300 beds.
DMC is a 100% private hospital located south of Johannesburg to serve the communities of Lenasia South, Orange Farm, Ennerdale, Evaton, Sebokeng and Vereeniging.
Oaklins' team in South Africa acted as corporate and financial advisor to the buyer in this transaction.
Talk to the deal team
Related deals
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Learn morebioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Learn moreSLT has been acquired by Indutrade
SLT S.r.l. has been acquired by Indutrade AB and will be integrated into the group’s life science business area. The transaction is Indutrade’s fifth acquisition in 2025 and is expected to have a marginally positive impact on the group’s earnings per share.
Learn more